AVITA Medical (RCEL) Invested Capital (2019 - 2025)

AVITA Medical (RCEL) has 7 years of Invested Capital data on file, last reported at $26.3 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 485.33% year-over-year to $26.3 million; the trailing twelve-month figure through Dec 2025 stood at $26.3 million (up 485.33% YoY), and the FY2025 full-year result was $26.3 million, up 485.33% from the prior year.
• Invested Capital for Q4 2025 stood at $26.3 million, down from $35.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $118.9 million in Q1 2021 and bottomed at -$9.9 million in Q2 2025.
• The 5-year median for Invested Capital is $65.8 million (2023), against an average of $59.8 million.
• Peak annual rise in Invested Capital reached 485.33% in 2025, while the deepest fall reached 141.36% in 2025.
• A 5-year view of Invested Capital shows it stood at $104.6 million in 2021, then dropped by 19.01% to $84.7 million in 2022, then slumped by 42.11% to $49.1 million in 2023, then sank by 90.83% to $4.5 million in 2024, then surged by 485.33% to $26.3 million in 2025.
• The last three Invested Capital figures came in at $26.3 million (Q4 2025), $35.8 million (Q3 2025), and -$9.9 million (Q2 2025), per Business Quant data.

Peer Comparison